CWBHF · Charlotte's Web Holdings, Inc.
Market Cap
$71.62M
Shares
271.29M
Volume · Oct 19
128.3K
Avg daily vol (3M)
186.2K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.26
Open$0.22
Day$0.22–0.26
52W close$0.09–0.92
Avg vol 30d144K
Short int296K · 0.1% float · 1.5d
Short vol7%
Last earningsAug 13, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 13, 2026
Est · unconfirmed
· in 3 wks
filed Aug 13, 2026
call held Mar 31, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$46.84M
Trailing 12 months
Net income (TTM)
−$34.48M
Trailing 12 months
Revenue growth YoY
-15.2%
Year over year
Operating margin
-41.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$13.99M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+25.3%
Year over year · more shares
Price change (1Y)
+34.0%
Trailing year
Short interest
0.1%
Latest settlement · 1.5 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−41%
below
Price vs 50-day avg
−11%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
21%
mid-range
Momentum
relative strength
1-month return
−20%
trailing
6-month return
−57%
trailing
YTD return
−28%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ
Insider flow
Accumulating
Net +$39.3K over 90 days · 0% sells
Short interest
Falling
0.11% of float · ▼ -16.4% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — mid 3-yr range
Squeeze score
29
low risk · 0–100
Fundamentals
Revenue growth
+0%
Y/Y
Gross margin
43%
expanding
EPS growth
0%
Y/Y
Quant / Vol
risk profile
Volatility
131%
annualized · 1-yr
Max drawdown
−77%
past year
ATR
12.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 13, 2026
target range of approximately 50%
Gross margin
50%
normalized range of approximately $10 million
Quarterly SG&A
$10M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−41%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
21%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ
Insider flow
Accumulating
Net +$39.3K over 90 days · 0% sells
Short interest
Falling
0.11% of float · ▼ -16.4% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 21%
Range high $1
vs 200-day avg -41%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$4.65M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Capital expenditures | 50K | Six Months Ended June 30, 2026 | — |
| EBITDA non-GAAP | -$12.83M | Six Months Ended June 30, 2026 | — |
| Gross margin | 47.5% | Three Months Ended June 30, 2026 | — |
| Operating cash use | $0.9M | Three Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CWBHF
this stock
Charlotte's Web Holdings, Inc.
|
$71.62M | -28.1% | +0.5% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$62.65B | +28.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$48.88B | +1.1% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$48.14B | +30.9% | +4.3% | 67.7 | 2.6% |
|
HLN
Haleon plc
|
$44.72B | +0.6% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CWBHF | +5.1% | -20.1% | -56.7% | -3.4% | -28.2% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | +6.6% | -19.2% | -64.4% | -3.9% | -40.6% |